Market Research Logo

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2018-2030

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2018-2030

This report studies the mRNA Vaccines & Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the mRNA Vaccines & Therapeutics market by product type and applications.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The major players in global mRNA Vaccines & Therapeutics market include
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of mRNA Vaccines & Therapeutics in these regions, from 2020 to 2030 (forecast), covering
North America
Europe
Asia Pacific
South America
Middle East and Africa

On the basis on the end users/applications, this report covers
Infectious Disease
Cancer
Other


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market by Application
1.4.1 Global mRNA Cancer Vaccines and Therapeutics Expenses Comparison by Applications (2013-2025)
1.4.2 Infectious Disease
1.4.3 Cancer
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Expense by Regions (2013-2025)
2.2.2 mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Substitutes Threat
2.3.3 DNA/mRNA Advantages over Traditional Vaccines
3 Market Share by Key Players
3.1 mRNA Cancer Vaccines and Therapeutics Market Size by Manufacturers
3.1.1 Global mRNA Cancer Vaccines and Therapeutics Expenses by Manufacturers (2017-2018)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Manufacturers (2017-2018)
3.1.3 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR3)
3.2 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.3 Pipeline Analysis of mRNA Cancer Vaccines and Therapeutics
3.4 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Application
5 North America
5.1 North America mRNA Cancer Vaccines and Therapeutics Expense (2013-2018)
5.2 North America mRNA Cancer Vaccines and Therapeutics Expense and Market Share by Players
5.3 North America mRNA Cancer Vaccines and Therapeutics Expense and Market Share by Applications
6 Europe
6.1 Europe mRNA Cancer Vaccines and Therapeutics Expenses (2013-2018)
6.2 Europe mRNA Cancer Vaccines and Therapeutics Expenses and Market Share by Players
6.3 Europe mRNA Cancer Vaccines and Therapeutics Expenses and Market Share by Applications
7 Major Cancer Analysis
7.1 Colorectal Cancer
7.1.1 Colorectal Cancer Introduction
7.1.2 Introduction of the Number of Patients with Colorectal Cancer
7.2 Lung Cancer
7.2.1 Lung Cancer Introduction
7.2.2 Introduction of the Number of Patients with Lung Cancer
7.3 Pancreatic Cancer
7.3.1 Pancreatic Cancer Introduction
7.3.2 Introduction of the Number of Patients with Pancreatic Cancer
7.4 Breast Cancer
7.4.1 Breast Cancer Introduction
7.4.2 Introduction of the Number of Patients with Breast Cancer
7.5 Prostate Cancer
7.5.1 Prostate Cancer Introduction
7.5.2 Introduction of the Number of Patients with Prostate Cancer
7.6 Other Cancer
8 Company Profiles
8.1 Companies with mRNA Programs
8.1.1 Alexion Pharmaceuticals
8.1.2 Vertex Pharmaceuticals
8.1.3 Ultragenyx Pharmaceutical
8.2 Companies focus on mRNA Delivery
8.2.1 Acuitas Therapeutics
8.2.2 Silence Therapeutics
8.2.3 Arcturus Therapeutics
9 Pipeline Analysis of mRNA Cancer Vaccines and Therapeutics Key Manufacturers
9.1 Pipeline Analysis of mRNA Cancer Vaccines and Therapeutics
9.2 Main Pipeline Product Analysis
9.2.1 IVAC-Mutanome
9.2.2 FixVax
9.2.3 CV8102
9.2.4 CV7201
9.2.5 AGS-004
9.2.6 MRT5005 & MRT5201
9.2.7 SB-FIX & SB-318 & SB-913
9.2.8 mRNA-1647
9.2.9 mRNA-4157
9.2.10 mRNA-1653
10 Major Pharmaceutical Companies with mRNA Programs
10.1 Boehringer Ingelheim
10.2 Novartis
10.3 Merck
10.4 AstraZeneca
10.5 Roche
10.6 Sanofi
10.7 Takeda
10.8 Johnson & Johnson
10.9 Bayer
10.10 ZIOPHARM Oncology
10.11 MaxCyte
10.12 Casebia Therapeutics
10.13 Intellia Therapeutics
11 mRNA Cancer Vaccines and Therapeutics Manufacturing Cost Analysis
11.1 mRNA Cancer Vaccines and Therapeutics Key Raw Materials Analysis
11.1.1 Clinical Phase Costs
11.1.2 Capitalized Costs
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Other Costs Analysis
11.2.4 Manufacturing Expenses
11.3 Comparison of Production Processes for Traditional, mRNA and DNA vaccines
12 Analysis of mRNA Cancer Vaccines and Therapeutics Industry Key Manufacturers
12.1 Moderna Therapeutics
12.1.1 Company Profile
12.1.2 Product Information
12.1.3 Expenses, R&D Share
12.2 CureVac
12.2.1 Company Profile
12.2.2 Product Information
12.2.3 Expenses, R&D Share
12.3 RaNa Therapeutics (Translate Bio)
12.3.1 Company Profile
12.3.2 Product Information
12.3.3 Expenses, R&D Share
12.4 BioNTech
12.4.1 Company Profile
12.4.2 Product Information
12.4.3 Expenses, R&D Share
12.5 Sangamo Therapeutics
12.5.1 Company Profile
12.5.2 Product Information
12.5.3 Expenses, R&D Share
12.6 Argos Therapeutics
12.6.1 Company Profile
12.6.2 Product Information
12.6.3 Expenses, R&D Share
12.7 In-Cell-Art
12.7.1 Company Profile
12.7.2 Product Information
12.7.3 Expenses, R&D Share
12.8 eTheRNA
12.8.1 Company Profile
12.8.2 Product Information
12.8.3 Expenses, R&D Share
12.9 Ethris
12.9.1 Company Profile
12.9.2 Product Information
12.9.3 Expenses, R&D Share
12.10 Tiba Biotechnology
12.10.1 Company Profile
12.10.2 Product Information
12.10.3 Expenses, R&D Share
13 Market Forecast 2020-2030
13.1 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast (2020-2030)
13.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast by Regions (2020-2030)
13.2.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.2.2 North America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.2.3 Europe mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.2.4 Asia Pacific mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.2.5 South America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.2.6 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate Forecast (2020-2030)
13.3 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Application (2020-2030)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.3 Author Details
List of Table and Figure
Figure Product Picture of mRNA Cancer Vaccines and Therapeutics
Table mRNA Cancer Vaccines and Therapeutics Key Market Segments
Table Key Players mRNA Cancer Vaccines and Therapeutics Covered
Table Scope of Clinical mRNA Applications
Figure Global Expenses Market Share of mRNA Cancer Vaccines and Therapeutics by Applications in 2017
Figure Infectious Disease Examples
Figure Cancer Examples
Figure mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure Global Market mRNA Cancer Vaccines and Therapeutics Revenue (M USD) Comparison by Regions 2020-2030
Table Global mRNA Cancer Vaccines and Therapeutics Expense (M USD) by Regions 2013-2025 (M USD)
Table Global mRNA Cancer Vaccines and Therapeutics Expenses (M USD) and Market Share by Regions (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Regions (2013-2018)
Figure Expenses Market Share of mRNA Cancer Vaccines and Therapeutics by Regions (2013-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Regions in 2017
Figure mRNA Cancer Vaccines and Therapeutics Discovery and Development Analysis
Figure Picture of RNAi for Therapeutic
Table Global mRNA Cancer Vaccines and Therapeutics Expenses by Manufacturers (2017-2018) (M USD)
Table Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Manufacturers (2017-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Manufacturers in 2017
Figure Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Manufacturers in 2018
Table Global mRNA Cancer Vaccines and Therapeutics Manufacturers Market Concentration Ratio (CR3) in 2017
Table Key Players Head office and Area Served
Table Pipeline Analysis mRNA Cancer Vaccines and Therapeutics
Table Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table Global mRNA Cancer Vaccines and Therapeutics Expenses (M USD) by Application (2013-2018)
Table Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Application (2013-2018)
Figure Expenses Market Share of mRNA Cancer Vaccines and Therapeutics by Application (2013-2018)
Figure Global mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Application in 2017
Figure North America mRNA Cancer Vaccines and Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Expenses (M USD) by Players (2017-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Players (2017-2018)
Figure North America mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Players in 2017
Table North America mRNA Cancer Vaccines and Therapeutics Expenses (M USD) by Applications (2013-2018)
Table North America mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Applications (2013-2018)
Figure North America mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Applications in 2017
Figure Europe mRNA Cancer Vaccines and Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Expenses (M USD) by Players (2017-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Players (2017-2018)
Figure Europe mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Players in 2017
Table Europe mRNA Cancer Vaccines and Therapeutics Expenses (M USD) by Applications (2013-2018)
Table Europe mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Applications (2013-2018)
Figure Europe mRNA Cancer Vaccines and Therapeutics Expenses Market Share by Applications in 2017
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016
Top 20 Countries Highest Incidence of Lung Cancer in 2016
Figure Percent of New Cases by Age Group: Lung Cancer
Figure Percent of Deaths by Age Group: Lung Cancer
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016
Top 20 Countries Highest Incidence of Breast Cancer in 2016
Figure Percent of New Cases by Age Group: Prostate Cancer
Figure Percent of Deaths by Age Group: Prostate Cancer
Figure Estimated Prostate Cancer Incidence Worldwide in 2016
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016
Table Alexion Pharmaceuticals Company Profile
Table Vertex Pharmaceuticals Company Profile
Table Ultragenyx Pharmaceutical Company Profile
Table Acuitas Therapeutics Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of Acuitas Therapeutics
Table Silence Therapeutics Company Profile
Table Table Product Information
Table Arcturus Therapeutics Company Profile
Table Product Information
Table Pipeline Analysis mRNA Cancer Vaccines and Therapeutics
Figure IVAC-Mutanome Pipeline
Figure FixVax Pipeline
Figure CV8102 Pipeline
Figure CV7201 Pipeline
Figure CV7201 Pipeline
Figure MRT5005 & MRT5201 Pipeline
Figure SB-FIX Pipeline
Figure SB-318 & SB-913 Pipeline
Figure mRNA-1647 Pipeline
Figure mRNA-4157 Pipeline
Figure mRNA-1653 Pipeline
Table Boehringer Ingelheim Company Profile
Table Novartis Company Profile
Table Merck Company Profile
Table AstraZeneca Company Profile
Table Roche Company Profile
Table Sanofi Company Profile
Table Takeda Company Profile
Table Johnson & Johnson Company Profile
Table Bayer Company Profile
Table ZIOPHARM Oncology Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of ZIOPHARM Oncology
Table MaxCyte Company Profile
Table Casebia Therapeutics Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of Casebia Therapeutics
Table Intellia Therapeutics Company Profile
Table Product Information
Figure Typical Phases from Research to the Market for a Cancer Vaccine Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure USA Labor Cost Analysis 2015-2018
Figure Cost of Employing a Factory Worker
Figure Europe Labor Cost Analysis 2015-2018
Figure Germany Labor Cost Analysis 2015-2018
Figure UK Labor Cost Analysis 2015-2018
Figure France Labor Cost Analysis 2015-2018
Figure Italy Labor Cost Analysis 2015-2018
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2015-2018
Figure Japan Average Monthly Wages 2015-2018
Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour)
Table Average Price of Electricity to Ultimate Customers 2007-2018
Figure Electricity Prices for Household Consumers in 2017
Table China Cost of Electricity 2017 (PER KWH)
Figure Comparison of Production Processes for Traditional, mRNA and DNA Vaccines
Figure Differences between Traditional, mRNA and DNA Vaccines
Figure History of Vaccine Development
Figure Differences between Traditional, MRNA and DNA Vaccines (Delivery)
Table Moderna Therapeutics Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Picture of Moderna Therapeutics
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Moderna Therapeutics 2017-2018
Table CureVac Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of CureVac
Figure mRNA Cancer Vaccines and Therapeutics Product Information of CureVac
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of CureVac 2017-2018
Table Translate Bio Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Picture of Translate Bio
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Translate Bio 2017-2018
Table BioNTech Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of BioNTech
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of BioNTech 2017-2018
Table Sangamo Therapeutics Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Picture of Sangamo Therapeutics
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Sangamo Therapeutics 2017-2018
Table Argos Therapeutics Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Picture of Argos Therapeutics
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Argos Therapeutics 2017-2018
Table In-Cell-Art Company Profile
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of In-Cell-Art 2017-2018
Table eTheRNA Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of eTheRNA
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of eTheRNA 2017-2018
Table Ethris Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Information of Ethris
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Ethris 2017-2018
Table Tiba Biotechnology Company Profile
Figure mRNA Cancer Vaccines and Therapeutics Product Picture of Tiba Biotechnology
Table mRNA Cancer Vaccines and Therapeutics Expenses (M USD), R&D Share of Tiba Biotechnology 2017-2018
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue (M USD) Forecast by Regions (2020-2025)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue (M USD) Forecast by Regions (2025-2030)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share Forecast by Regions (2020-2030)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure North America mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Figure Europe mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Figure Asia Pacific mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Figure South America mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Figure Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue (M USD) and Growth Rate Forecast (2020-2030)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue (M USD) Forecast by Application (2020-2025)
Table Global mRNA Cancer Vaccines and Therapeutics Revenue (M USD) Forecast by Application (2025-2030)
Figure Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share Forecast by Application (2020-2030)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report